Anna Cioce

Anna Cioce

Auto-generated profile, based on publicly available information

Anna Cioce

Department of Chemistry, Imperial College London, London, UK

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
ACAnna Cioce
Anna Cioce
BCBeatriz Calle
Beatriz Calle
TRTatiana Rizou
Tatiana Rizou
SLSarah C. Lowery
Sarah C. Lowery
VBVictoria L. Bridgeman
Victoria L. Bridgeman
BSBenjamin Schumann
Benjamin Schumann
Altered glycoprotein expression is an undisputed corollary of cancer development. Understanding these alterations is paramount but hampered by limitations underlying cellular model systems. For instance, the intricate interactions between tumour and host cannot be adequately recapitulated in monoculture of tumour-derived cell lines. More complex co-culture models usually rely on sorting procedures for proteome analyses and rarely capture the details of protein glycosylation. Here, we report a strategy termed Bio-Orthogonal Cell line-specific Tagging of Glycoproteins (BOCTAG). Cells are equipped by transfection with an artificial biosynthetic pathway that transforms bioorthogonally tagged sugars into the corresponding nucleotide-sugars. Only transfected cells incorporate bioorthogonal tags into glycoproteins in the presence of non-transfected cells. We employ BOCTAG as an imaging technique and to annotate cell-specific glycosylation sites in mass spectrometry-glycoproteomics. We demonstrate application in co-culture and mouse models, allowing for profiling of the glycoproteome as an important modulator of cellular function.

1 February 2020 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SPSilvana Pedatella
Silvana Pedatella
Carmen CerchiaCarmen Cerchia
Carmen Cerchia
MMMichele Manfra
Michele Manfra
ACAnna Cioce
Anna Cioce
ABAdele Bolognese
Adele Bolognese
Antonio LavecchiaAntonio Lavecchia
Antonio Lavecchia

13 August 2021 in Organic & Biomolecular Chemistry
Verified
Journal Article
Open access
PDF file
AMAntonio Di Maio
Antonio Di Maio
ACAnna Cioce
Anna Cioce
SASilvia Achilli
Silvia Achilli
MTMichel Thépaut
Michel Thépaut
CVCorinne Vivès
Corinne Vivès
NRNiels-C. Reichardt
Niels-C. Reichardt
Density depended binding and selectivity is studied on glycodendron microarray with defined valency, which were prepared by on-chip synthesis and analysed by in situ MALDI-TOF MS.

22 August 2024 in RSC Chemical Biology
Verified
Journal Article
Open access
PDF file
AZAbdul Zafar
Abdul Zafar
SSSandhya Sridhar
Sandhya Sridhar
GBGanka Bineva-Todd
Ganka Bineva-Todd
ACAnna Cioce
Anna Cioce
NANadia Abdulla
Nadia Abdulla
BSBenjamin Schumann
Benjamin Schumann
Glycosylation is a ubiquitous modification of proteins, necessitating approaches for its visualization and characterization. Bioorthogonally tagged monosaccharides have been instrumental to this end, offering a chemical view into the cell biology of glycans. Understanding the use of such monosaccharides by cellular biosynthetic pathways has expanded their applicability in cell biology, for instance through the strategy named Bio-Orthogonal Cell-specific TAgging of Glycoproteins (BOCTAG). Here, we show that the cellular use of two azide-tagged analogues of the monosaccharide N-acetylgalactosamine (GalNAzMe and GalNPrAz) can be promoted through expression of two biosynthetic enzymes. More precisely, cellular expression of the bacterial kinase NahK and the engineered human pyrophosphorylase AGX1F383A led to biosynthesis of the corresponding activated nucleotide-sugars and subsequent bioorthogonal tagging of the cellular glycoproteome. We explore the use of both sugars for BOCTAG, demonstrating the visualization of cell surface glycosylation tagged with GalNPrAz in a specific cell line in a co-culture system. Our work adds to the toolbox of glycoprotein analysis in biomedicine.

20 January 2026 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
ZLZhen Li
Zhen Li
HCHimanshi Chawla
Himanshi Chawla
LVLucia Di Vagno
Lucia Di Vagno
ACAisling Ní Cheallaigh
Aisling Ní Cheallaigh
MCMeg Critcher
Meg Critcher
BSBenjamin Schumann
Benjamin Schumann
Mammalian cells receive signaling instructions through interactions on their surfaces. Proteoglycans are critical to these interactions, carrying long glycosaminoglycans that recruit signaling molecules. Biosynthetic redundancy in the first glycosylation step by two xylosyltransferases XT1/2 complicates annotation of proteoglycans. Here we develop a chemical genetic strategy that manipulates the glycan attachment site of cellular proteoglycans. Through a bump-and-hole tactic, we engineer the two isoenzymes XT1 and XT2 to specifically transfer the chemically tagged xylose analog 6AzGlc to target proteins. The tag contains a bioorthogonal functionality, allowing to visualize and profile target proteins in mammalian cells. Unlike xylose analogs, 6AzGlc is amenable to cellular nucleotide-sugar biosynthesis, establishing the XT1/2 bump-and-hole tactic in cells. The approach allows pinpointing glycosylation sites by mass spectrometry and exploiting the chemical handle to manufacture proteoglycans with defined glycosaminoglycan chains for cellular applications. Engineered XT enzymes permit an orthogonal view into proteoglycan biology through conventional techniques in biochemistry.

20 December 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
ZLZhen Li
Zhen Li
LVLucia Di Vagno
Lucia Di Vagno
HCHimanshi Chawla
Himanshi Chawla
ACAisling Ni Cheallaigh
Aisling Ni Cheallaigh
MCMeg Critcher
Meg Critcher
BSBenjamin Schumann
Benjamin Schumann
Mammalian cells orchestrate signalling through interaction events on their surfaces. Proteoglycans are an intricate part of these interactions, carrying large glycosaminoglycan polysaccharides that recruit signalling molecules. Despite their importance in development, cancer and neurobiology, a relatively small number of proteoglycans have been identified. In addition to the complexity of glycan extension, biosynthetic redundancy in the first protein glycosylation step by two xylosyltransferase isoenzymes XT1 and XT2 complicates annotation of proteoglycans. Here, we develop a chemical genetic strategy that manipulates the glycan attachment site of cellular proteoglycans. By employing a tactic termed bump- and-hole engineering, we engineer the two isoenzymes XT1 and XT2 to specifically transfer a chemically modified xylose analogue to target proteins. The chemical modification contains a bioorthogonal tag, allowing the ability to visualise and profile target proteins modified by both transferases in mammalian cells. The versatility of our approach allows pinpointing glycosylation sites by tandem mass spectrometry, and exploiting the chemical handle to manufacture proteoglycans with defined GAG chains for cellular applications. Engineered XT enzymes permit a view into proteoglycan biology that is orthogonal to conventional techniques in biochemistry.